Prepare a destination-specific brief
For a United States or Canadian enquiry, identify the receiving institution and the exact purpose of the proposed material before requesting a shipping quotation. State the delivery address, responsible importer and the documents your organization needs for its review. Ask whether the material description on the quotation, SDS, label and invoice is consistent. A research-use label should not be treated as a universal exemption from applicable requirements.
CBL-514 clinical trial activity in North America does not establish that unrelated commercial material is authorized for sale or import. Keep the study pathway separate from a laboratory procurement discussion. If the project is a general peptide or lyophilized powder OEM request, provide the sequence or identity, quantity and packaging needs so the team can assess a defined scope. Use the official FDA and Health Canada resources, together with your institution’s qualified advisers, to check the current requirements relevant to the actual transaction.
Frequently asked questions
What should a US laboratory check before a CBL-514 enquiry?
Define the exact material and intended laboratory use, then review relevant US authority information and import responsibilities. A research-use label or an online listing is not a general authorization to import or administer.
What should a Canadian recipient verify?
Confirm the exact material, intended research use, receiving entity and applicable Canadian requirements. A supplier's general shipping statement does not resolve the recipient's import or handling responsibilities.